PLAT and empyema: In this single center, retrospective study of patients presenting with complicated parapneumonic effusion or empyema, the use of once daily concurrently administered tPA/DNAse led to comparable rates of the primary efficacy outcome of treatment success as prior studies utilizing twice daily concurrent or sequential dosing.